8 Lessons Learned: Options

Things that You Have to Know About Bipolar Depression

The bipolar disorder is a kind of condition which affects all types of people. The children and adults are being affected by such condition. This is a fact that you should know. Women would suffer the most from this kind of depression that is called bipolar depression disorder.

This is not really strange or far-fetched in any case because even if the women would suffer from the regular bipolar type of depression or depressive disorder, they are going to spend more time depressed than they would do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.

The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.

Such kind of depression is a form of disorder and you must understand that it is easy to mistakenly diagnose as bipolar disorder because of the sameness of these symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It is surely not flattering to either of you when you get treated for a wrong thing.

The bipolar affective disorder is simply another name for such bipolar disorder or the manic-depressive illness. However, you don’t want to mistake such for bipolar depression disorder. Such is related with those symptoms of such depressive phase of bipolar disorder but only a few of the mania.

Monotherapy trials against the placebo is the gold-standard design when determining the efficacy in treating bipolar depression. When such efficacy would be proven as monotherapy, the new compounds can be tested in the adjunctive-medication placebo-controlled trials. The younger adults, without the need for the long-term medication can be fit for the clinical trials which need placebo-controls. The switch to mania or hypomania can be the consequence of such active treatment for the bipolar depression.

Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. The 12-week trials against placebo are needed to determine the risk of switch and also to establish the continuing effects. You should know that careful assessment at 6-8 weeks are required to make sure that the patients who fail to respond won’t continue in the study for the unacceptable periods of time.